Cargando…
Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years’ discoveries and developments
Knowledge of the molecular mechanisms on malignant tumors is very critical for the development of new treatment strategies like molecularly targeted therapies. In last 5 years, many investigations suggest that stathmin is over-expressed in a variety of human malignant tumors, and potentially promote...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037901/ https://www.ncbi.nlm.nih.gov/pubmed/27670291 http://dx.doi.org/10.1186/s12967-016-1000-z |